Thomas Karn

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani et al. · The Lancet Oncology · 2017 · 2K citations

Breast Oncology, Neoadjuvant Therapy, Medicine +9

Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

Manfred Kaufmann, Gϋnter von Minckwitz, E Mamounas et al. · Annals of Surgical Oncology · 2011 · 481 citations

Surgical Oncology, Breast Oncology, Medicine +8

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Uwe Holtrich, L. Pusztai et al. · Breast Cancer Research · 2009 · 476 citations · Full text

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer

Eric Hahnen, Bianca Lederer, Jan Hauke et al. · JAMA Oncology · 2017 · 385 citations · Full text

A clinically relevant gene signature in triple negative and basal-like breast cancer

Achim Rody, Thomas Karn, Cornelia Liedtke et al. · Breast Cancer Research · 2011 · 329 citations · Full text